BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. – Regeneron Pharmaceuticals, Inc. Transaction History
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. portfolio value:
$48.24M
portfolio value
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +168.25% | 43.92K shares | 32.81M | $688.87 | 70.03K |
Q2 2022 | share | Increase | +9.00% | 2.15K shares | -1.29M | $591.13 | 26.10K |
Q1 2022 | share | Increase | +42.98% | 7.2K shares | 6.15M | $698.42 | 23.95K |
Q4 2021 | share | Increase | +124.23% | 9.28K shares | 6.05M | $642.51 | 16.75K |
Q3 2021 | share | Increase | +5.66% | 400 shares | 572K | $605.18 | 7.47K |
Q2 2021 | share | Decrease | -17.05% | -1.45K shares | -84K | $558.54 | 7.07K |
Q1 2021 | share | Decrease | -4.63% | -414 shares | -285K | $473.14 | 8.52K |
Q4 2020 | share | Increase | +0.56% | 50 shares | -657K | $483.11 | 8.93K |
Q3 2020 | share | Increase | +103.85% | 4.52K shares | 2.25M | $559.78 | 8.88K |
Q2 2020 | share | Decrease | -21.53% | -1.19K shares | 6K | $623.65 | 4.36K |
Q1 2020 | share | Increase | +73.68% | 2.35K shares | 1.51M | $488.29 | 5.55K |
Q4 2019 | share | Decrease | -30.23% | -1.38K shares | -71K | $375.48 | 3.19K |
Q3 2019 | share | Decrease | -22.08% | -1.29K shares | -570K | $277.4 | 4.58K |
Q2 2019 | share | Increase | +195.83% | 3.89K shares | 1.02M | $313 | 5.88K |
Q1 2019 | share | Decrease | -7.19% | -154 shares | 40K | $410.62 | 1.98K |
Q4 2018 | share | Increase | +10.12% | 197 shares | -9K | $373.5 | 2.14K |
Q3 2018 | share | Increase | +6.69% | 122 shares | 157K | $404.04 | 1.94K |
Q2 2018 | share | 0.00% | 0 shares | 1K | $344.99 | 1.82K | |
Q1 2018 | share | Increase | +16.62% | 260 shares | 40K | $344.36 | 1.82K |
Q4 2017 | share | Decrease | -8.05% | -137 shares | -173K | $375.96 | 1.56K |
Q3 2017 | share | Decrease | -20.25% | -432 shares | -287K | $447.12 | 1.70K |
Q2 2017 | share | Decrease | -21.61% | -588 shares | -6K | $491.14 | 2.13K |
Q1 2017 | share | Decrease | -22.50% | -790 shares | -235K | $387.51 | 2.72K |
Q4 2016 | share | Decrease | -56.83% | -4.62K shares | -1.98M | $367.09 | 3.51K |
Q3 2016 | share | Decrease | -3.22% | -271 shares | 334K | $402.02 | 8.13K |
Q2 2016 | share | Increase | +5.05% | 404 shares | 51K | $349.23 | 8.40K |
Q1 2016 | share | Increase | +2.25% | 176 shares | -1.36M | $360.44 | 8K |